COMMUNIQUÉS West-GlobeNewswire

Rockwell Medical, Inc. to Present at Upcoming September Conferences
28/08/2019
WIXOM, Mich., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, is scheduled to present at two [...]
Flexion Therapeutics to Present at the Wells Fargo Securities 2019 Healthcare Conference
28/08/2019
BURLINGTON, Mass., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led [...]
Atara Biotherapeutics to Participate in Citi 14th Annual Biotech Conference
28/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Acasti Pharma Announces the Election of Its Directors, Amendments to Its Stock Option and Equity Incentive Plans and Other Related Matters Approved at Its AGM
28/08/2019
LAVAL, Quebec, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Corporation”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization [...]
Bellicum Pharmaceuticals to Participate in Three Healthcare Investor Conferences during September
28/08/2019
HOUSTON, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
MyoKardia to Participate in September Investor Conferences
28/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced its participation in the following upcoming investor conferences: Citi 14 th Annual Biotech Conference in [...]
Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences
28/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced that Gerald [...]
Establishment Labs to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
28/08/2019
NEW YORK, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]
Autolus Therapeutics to Participate in Upcoming Investor Conferences in September
28/08/2019
LONDON, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that management will [...]
Ziopharm Oncology to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
28/08/2019
BOSTON, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq: ZIOP) today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer of Ziopharm, will participate in a webcast fireside chat at [...]
Kezar Life Sciences Announces Presentations at Upcoming Investor Conferences
28/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet [...]
Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushing’s Syndrome
28/08/2019
MENLO PARK, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for a patent [...]
Diversicare's Common Stock Will be Traded on the OTCQX Following the Delisting From NASDAQ
28/08/2019
BRENTWOOD, Tenn., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR) was notified by The Nasdaq Stock Market LLC ("Nasdaq") that the Nasdaq Hearings Panel denied the Company’s recent [...]
CB2 Insights Reports Second Quarter Fiscal 2019 Financial Results, Sees Positive Impact from New Acquisitions
28/08/2019
Revenue Increases 14% Over the Prior Quarter; 14% Improvement in Net Income/Loss Position TORONTO, Aug. 28, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB:CBIIF) (“ CB2 ” or the “ Company ”), a leading [...]
Alder BioPharmaceuticals® to Present at Two Upcoming September Investor Conferences
28/08/2019
BOTHELL, Wash., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Transparency notification – Gilead holds 22% of Galapagos shares
28/08/2019
Mechelen, Belgium; 28 August 2019; 22.01 CEST; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Gilead Sciences, Inc. Pursuant to Belgian transparency [...]
Reata Appoints Manmeet S. Soni as Chief Financial Officer; Jason D. Wilson to Assume New Role as EVP, Operations
28/08/2019
IRVING, Texas, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced the appointment of Manmeet S. Soni as Chief Financial Officer (CFO [...]
Ascendis Pharma A/S Reports Second Quarter 2019 Financial Results
28/08/2019
– TransCon hGH moves towards Biologics License Application submission following completion of heiGHt and fliGHt Trials – – Global reach of endocrinology rare disease programs expands – – Conference call today at 4:30 p. [...]
Trevena Advances NDA Resubmission Activities for Oliceridine
28/08/2019
— Completed enrollment in healthy volunteer QT study, topline data expected in Q4 2019 — — Completed characterization of inactive metabolite — — Remains on track to resubmit NDA in Q1 2020 — CHESTERBROOK, Pa., Aug. 28, [...]

Pages